{
  "success": true,
  "pagesUsed": [
    1,
    2,
    4,
    9,
    16,
    21,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SUMMARY",
        "text": "PROTOCOL SUMMARY",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "PROTOCOL SUMMARY",
        "sectionType": {
          "id": "f16b134d-a84a-4cfe-9c28-b5d147844017",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_1_1",
          "nci_1_2",
          "nci_1_3"
        ]
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "2a78d0c8-d16a-4519-9e01-f0d0d74a0c7e",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3"
        ]
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVES AND ENDPOINTS",
        "text": "OBJECTIVES AND ENDPOINTS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "id": "d0f8d152-4f42-489a-bf72-017d14dde8c1",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1"
        ]
      },
      {
        "id": "nc_4",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "86d914d6-db0f-47f6-9cb6-530515441e72",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY POPULATION",
        "text": "STUDY POPULATION",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "STUDY POPULATION",
        "sectionType": {
          "id": "58e5b0bf-2777-4139-b77a-1a66e1d8b084",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1"
        ]
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_1_1",
        "name": "SYNOPSIS",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "SYNOPSIS"
      },
      {
        "id": "nci_1_2",
        "name": "SCHEMA",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "SCHEMA"
      },
      {
        "id": "nci_1_3",
        "name": "SCHEDULE OF ACTIVITIES (SOA)",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "SCHEDULE OF ACTIVITIES (SOA)"
      },
      {
        "id": "nci_2_1",
        "name": "STUDY RATIONALE",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "STUDY RATIONALE"
      },
      {
        "id": "nci_2_2",
        "name": "BACKGROUND",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "BACKGROUND"
      },
      {
        "id": "nci_2_3",
        "name": "BENEFIT/RISK ASSESSMENT",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "BENEFIT/RISK ASSESSMENT"
      },
      {
        "id": "nci_3_1",
        "name": "APPROPRIATENESS OF MEASUREMENTS",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "APPROPRIATENESS OF MEASUREMENTS"
      },
      {
        "id": "nci_4_1",
        "name": "OVERALL DESIGN",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "OVERALL DESIGN"
      },
      {
        "id": "nci_4_2",
        "name": "SCIENTIFIC RATIONALE FOR STUDY DESIGN",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "SCIENTIFIC RATIONALE FOR STUDY DESIGN"
      },
      {
        "id": "nci_4_3",
        "name": "JUSTIFICATION FOR DOSE",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "JUSTIFICATION FOR DOSE"
      },
      {
        "id": "nci_4_4",
        "name": "END OF STUDY DEFINITION",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4",
        "sectionTitle": "END OF STUDY DEFINITION"
      },
      {
        "id": "nci_4_5",
        "name": "STUDY STOPPING RULES",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.5",
        "sectionTitle": "STUDY STOPPING RULES"
      },
      {
        "id": "nci_5_1",
        "name": "INCLUSION CRITERIA",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "INCLUSION CRITERIA"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "ABR",
        "expandedText": "annualized bleed rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "ADA",
        "expandedText": "Anti-rFVIIIFc-VWF-XTEN Antibody",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "AE",
        "expandedText": "Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "aPTT",
        "expandedText": "activated partial thromboplastin time",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "EHL",
        "expandedText": "extended half-life",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "EOS",
        "expandedText": "End of Study",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "ePD",
        "expandedText": "electronic patient diary",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "ET",
        "expandedText": "Early Termination",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "FVIII",
        "expandedText": "Factor VIII",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "HBV",
        "expandedText": "Hepatitis B Virus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "HCV",
        "expandedText": "Hepatitis C Virus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "HIV",
        "expandedText": "Human Immunodeficiency Virus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "HJHS",
        "expandedText": "Hemophilia Joint Health Score",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "INN",
        "expandedText": "international nonproprietary name",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "ISTH",
        "expandedText": "International Society on Thrombosis and Haemostasis",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "PK",
        "expandedText": "Pharmacokinetics",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "PROMIS",
        "expandedText": "Patient-Reported Outcomes Measurement Information System",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "SAE",
        "expandedText": "Serious Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "SAP",
        "expandedText": "statistical analytical plan",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "SoA",
        "expandedText": "Schedule of Activities",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "TSQM-9",
        "expandedText": "9-item version of the Treatment Satisfaction Questionnaire for Medication",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 5,
      "itemCount": 13,
      "abbreviationCount": 21
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "Amended clinical Trial Protocol 05 EFC16293 - efanesoctocog alfa",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "1",
      "versionDate": "20-Aug-2021",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "ABR",
          "expansion": "annualized bleed rate"
        },
        {
          "abbreviation": "ADA",
          "expansion": "Anti-rFVIIIFc-VWF-XTEN Antibody"
        },
        {
          "abbreviation": "AE",
          "expansion": "Adverse Event"
        },
        {
          "abbreviation": "aPTT",
          "expansion": "activated partial thromboplastin time"
        },
        {
          "abbreviation": "EHL",
          "expansion": "extended half-life"
        },
        {
          "abbreviation": "EOS",
          "expansion": "End of Study"
        },
        {
          "abbreviation": "ePD",
          "expansion": "electronic patient diary"
        },
        {
          "abbreviation": "ET",
          "expansion": "Early Termination"
        },
        {
          "abbreviation": "FVIII",
          "expansion": "Factor VIII"
        },
        {
          "abbreviation": "HBV",
          "expansion": "Hepatitis B Virus"
        },
        {
          "abbreviation": "HCV",
          "expansion": "Hepatitis C Virus"
        },
        {
          "abbreviation": "HIV",
          "expansion": "Human Immunodeficiency Virus"
        },
        {
          "abbreviation": "HJHS",
          "expansion": "Hemophilia Joint Health Score"
        },
        {
          "abbreviation": "INN",
          "expansion": "international nonproprietary name"
        },
        {
          "abbreviation": "ISTH",
          "expansion": "International Society on Thrombosis and Haemostasis"
        },
        {
          "abbreviation": "PK",
          "expansion": "Pharmacokinetics"
        },
        {
          "abbreviation": "PROMIS",
          "expansion": "Patient-Reported Outcomes Measurement Information System"
        },
        {
          "abbreviation": "SAE",
          "expansion": "Serious Adverse Event"
        },
        {
          "abbreviation": "SAP",
          "expansion": "statistical analytical plan"
        },
        {
          "abbreviation": "SoA",
          "expansion": "Schedule of Activities"
        },
        {
          "abbreviation": "TSQM-9",
          "expansion": "9-item version of the Treatment Satisfaction Questionnaire for Medication"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "Amended clinical Trial Protocol 05 EFC16293 - efanesoctocog alfa",
        "version": "1",
        "versionDate": "20-Aug-2021"
      },
      "sections": [
        {
          "number": "1",
          "title": "PROTOCOL SUMMARY",
          "type": "Synopsis",
          "subsections": [
            {
              "number": "1.1",
              "title": "SYNOPSIS"
            },
            {
              "number": "1.2",
              "title": "SCHEMA"
            },
            {
              "number": "1.3",
              "title": "SCHEDULE OF ACTIVITIES (SOA)"
            }
          ]
        },
        {
          "number": "2",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "2.1",
              "title": "STUDY RATIONALE"
            },
            {
              "number": "2.2",
              "title": "BACKGROUND",
              "subsections": [
                {
                  "number": "2.2.1",
                  "title": "BIVV001"
                }
              ]
            },
            {
              "number": "2.3",
              "title": "BENEFIT/RISK ASSESSMENT"
            }
          ]
        },
        {
          "number": "3",
          "title": "OBJECTIVES AND ENDPOINTS",
          "type": "Objectives",
          "subsections": [
            {
              "number": "3.1",
              "title": "APPROPRIATENESS OF MEASUREMENTS"
            }
          ]
        },
        {
          "number": "4",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "4.1",
              "title": "OVERALL DESIGN"
            },
            {
              "number": "4.2",
              "title": "SCIENTIFIC RATIONALE FOR STUDY DESIGN"
            },
            {
              "number": "4.3",
              "title": "JUSTIFICATION FOR DOSE"
            },
            {
              "number": "4.4",
              "title": "END OF STUDY DEFINITION"
            },
            {
              "number": "4.5",
              "title": "STUDY STOPPING RULES",
              "subsections": [
                {
                  "number": "4.5.1",
                  "title": "Criteria for dose and/or enrollment suspension"
                }
              ]
            }
          ]
        },
        {
          "number": "5",
          "title": "STUDY POPULATION",
          "type": "Study Population",
          "subsections": [
            {
              "number": "5.1",
              "title": "INCLUSION CRITERIA"
            }
          ]
        }
      ]
    }
  }
}